.Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BB11_Glisoxepide.Glisoxepide .Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BB11_Glisoxepide.Glisoxepide| name: | Glisoxepide |
| ATC code: | A10BB11 | route: | oral |
| n-compartments | 1 |
Glisoxepide is a second-generation sulfonylurea oral hypoglycemic agent formerly used for the management of type 2 diabetes mellitus. It acts by stimulating insulin secretion from pancreatic beta cells. Its use has declined and it is not widely approved or available for current therapy.
Pharmacokinetic parameter values are estimated based on general properties of second-generation sulfonylureas, as no direct studies or clinical publication with detailed glisoxepide PK values have been identified.